Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$249,481
+$25,948 QoQ
Shares Held
208
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#4,292
of 4,605 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2020CallValue
$354,564
CallShares
2,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abbot Financial Management, Inc. holds $15,810,007 across 6 Drug Manufacturers - General names. LLY ranks #6 (1.6% of the industry book) .
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,481 | 208 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $223,533 | 208 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $201,994 | 228 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $206,426 | 228 | Shares | Sole | 2024-08-09 | |
| 2020-12-31 | $55,379 | 328 | Shares | Sole | 2021-02-11 | |
| 2020-12-31 | $354,564 | 2,100 | Call | Sole | 2021-02-11 | |
| 2020-09-30 | $310,842 | 2,100 | Call | Sole | 2020-10-26 | |
| 2020-09-30 | $48,550 | 328 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $53,851 | 328 | Shares | Sole | 2020-07-22 | |
| 2020-06-30 | $164,180 | 1,000 | Call | Sole | 2020-07-22 | |
| 2020-03-31 | $166,464 | 1,200 | Call | Sole | 2020-05-12 | |
| 2020-03-31 | $45,500 | 328 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||